NEW YORK – Lifebit Biotech said Thursday that it has received a four-year contract from the Danish National Genome Center (NGC) to support Denmark's national personalized medicine strategy. The firm did not disclose the value of the contract.
The London-based bioinformatics company will implement its Lifebit CloudOS software in the NGC's supercomputing cluster to create a federated trusted research environment for data management and analysis. In its current first phase, the program aims to sequence the genomes of 60,000 patients with cancer, autoimmune disorders, and rare diseases by 2024.
"This federated trusted research environment will enable researchers to more effectively collaborate over this rich dataset at scale and drive international collaboration between other government initiatives, many of which already leverage Lifebit's federated technology," Thorben Seeger, Lifebit's chief business development officer, said in a statement.
The company already works with other national biobanks in Europe and beyond, including Genomics England, France Génomique, Genomic Medicine Sweden, and the Hong Kong Genome Institute.